Dermatology · Panorama City, CA
NPI
1568782100
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13652 Cantara St, South One Bldg, Area 187
Panorama City, CA, 91402
Phone (818) 375-1720
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,706
50 services
Medicare patients, 2024
26
Average age 62
Drug cost, 2024
$1.2M
1,732 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Adam Rees prescribed most often to Medicare patients was Clobetasol Propionate, with 337 prescriptions and refills. In total Adam Rees wrote 1,732 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 337 | 377 | 164 | $8,534 |
| Triamcinolone Acetonide Generic | 160 | 205 | 99 | $3,556 |
| Hydrocortisone Generic | 99 | 105 | 41 | $1,723 |
| Tacrolimus Generic | 90 | 95 | 33 | $5,618 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 68 | 72 | 12 | $417K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 63 | 82 | 34 | $2,346 |
| Halobetasol Propionate Generic | 61 | 69 | 31 | $6,173 |
| Acitretin Generic | 56 | 70 | 14 | $5,974 |
| Fluorouracil Generic | 52 | 52 | 37 | $1,986 |
| Metronidazole Generic | 47 | 51 | 24 | $801 |
| Retin-A Tretinoin | 40 | 44 | 21 | $1,094 |
| Ketoconazole Generic | 39 | 47 | 14 | $685 |
| Dupixent Pen Dupilumab | 35 | 35 | Under 11 | $129K |
| Fluocinonide Generic | 34 | 34 | 20 | $591 |
| Terbinafine Hcl Generic | 31 | 69 | 27 | $739 |
Brand drugs: 286 claims; generic drugs: 1,446 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Adam Rees were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.